PROCEPT BioRobotics Corporation (PRCT)

Form SD - Specialized disclosure report

PROCEPT BioRobotics® Advances Prostate Cancer Program with WATER IV Study Enrollment Completion and Expanded IDE Approval

SAN JOSE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) today announced two...

AUA Guidelines Strengthen Recommendation for Aquablation® Therapy

SAN JOSE, Calif., May 14, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® (Nasdaq: PRCT) today highlighted the...

Form 3 - Initial statement of beneficial ownership of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

PROCEPT BioRobotics® to Attend Three Upcoming Investor Conferences in May & June

SAN JOSE, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a...

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form 8-K - Current report

Form 3 - Initial statement of beneficial ownership of securities

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEF 14A - Other definitive proxy statements

PROCEPT BioRobotics® to Report First Quarter 2026 Financial Results on April 29, 2026

SAN JOSE, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”...

Sonder Capital Closes its Second Fund and Announces Participation from Major Healthcare Systems

Sonder Capital Closes its Second Fund and Announces Participation from Major Healthcare Systems PR Newswire...

EAU Guidelines Upgrade Aquablation® Therapy to Strong Surgical Recommendation for BPH

SAN JOSE, Calif., March 23, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® (Nasdaq: PRCT) today highlighted...

Form 4 - Statement of changes in beneficial ownership of securities